SLC18A2 and thanatophoric dysplasia: The detection of functionally relevant SLC18A2 variants could allow identification of potential perturbations in VMAT2 function before the treatment initiation and would offer a window of opportunity to administer VMAT2 inhibitors along with the antipsychotic treatment to prevent TD development in the first place.